Table 2. Competitive Inhibition ELISA of IgGfrom Diabetes Type 2 Patients.

Sera No.	Maximum percent inhibition at 20 μg/ml
	N-IgG	OH•-IgG	MG-IgG	OH•-MG-IgG
9	20.1	52.7	58.7	72.3
12	31.7	50.1	52.1	73.6
20	33.8	57.7	54.4	70.2
32	32.6	51.6	57.9	78.5
36	35.1	59.9	51.6	69.4
51	27.7	63.4	55.7	80.8
63	39.7	64.2	56.7	78.7
65	32.4	57.1	65.5	76.6
69	30.1	56.3	52.8	71.5
71	41.7	62.2	56.3	75.4
Mean±SD	32.4±6.0	57.5±4.9	56.1±4.1	74.7±3.9

The microtitre plates were coated with 10 μg/ml of OH^•-MG-IgG